Fujian Aonong Biological Technology Group Incorporation Ltd
SSE:603363
Income Statement
Earnings Waterfall
Fujian Aonong Biological Technology Group Incorporation Ltd
Revenue
|
21.4B
CNY
|
Cost of Revenue
|
-21.3B
CNY
|
Gross Profit
|
70.6m
CNY
|
Operating Expenses
|
-1.6B
CNY
|
Operating Income
|
-1.5B
CNY
|
Other Expenses
|
-257.7m
CNY
|
Net Income
|
-1.8B
CNY
|
Income Statement
Fujian Aonong Biological Technology Group Incorporation Ltd
Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||
Revenue |
5 088
N/A
|
4 960
-3%
|
4 903
-1%
|
5 137
+5%
|
5 376
+5%
|
5 675
+6%
|
5 762
+2%
|
5 746
0%
|
5 736
0%
|
5 794
+1%
|
5 788
0%
|
6 197
+7%
|
7 165
+16%
|
8 860
+24%
|
11 517
+30%
|
13 663
+19%
|
15 649
+15%
|
17 504
+12%
|
18 038
+3%
|
18 299
+1%
|
18 636
+2%
|
20 119
+8%
|
21 613
+7%
|
22 276
+3%
|
22 862
+3%
|
21 387
-6%
|
|
Gross Profit | |||||||||||||||||||||||||||
Cost of Revenue |
(4 204)
|
(4 056)
|
(3 978)
|
(4 236)
|
(4 537)
|
(4 855)
|
(4 979)
|
(4 978)
|
(4 968)
|
(5 059)
|
(5 051)
|
(5 247)
|
(5 905)
|
(7 268)
|
(9 531)
|
(11 488)
|
(13 818)
|
(16 307)
|
(18 209)
|
(18 781)
|
(19 268)
|
(20 041)
|
(20 956)
|
(21 188)
|
(22 024)
|
(21 317)
|
|
Gross Profit |
884
N/A
|
904
+2%
|
924
+2%
|
901
-2%
|
839
-7%
|
820
-2%
|
782
-5%
|
768
-2%
|
768
+0%
|
735
-4%
|
737
+0%
|
950
+29%
|
1 260
+33%
|
1 592
+26%
|
1 986
+25%
|
2 175
+10%
|
1 831
-16%
|
1 197
-35%
|
(170)
N/A
|
(481)
-182%
|
(632)
-31%
|
77
N/A
|
657
+750%
|
1 088
+66%
|
838
-23%
|
71
-92%
|
|
Operating Income | |||||||||||||||||||||||||||
Operating Expenses |
(716)
|
(713)
|
(741)
|
(725)
|
(719)
|
(708)
|
(685)
|
(662)
|
(637)
|
(582)
|
(562)
|
(537)
|
(589)
|
(666)
|
(813)
|
(906)
|
(1 155)
|
(1 205)
|
(1 121)
|
(1 567)
|
(1 431)
|
(1 528)
|
(1 288)
|
(1 588)
|
(1 646)
|
(1 569)
|
|
Selling, General & Administrative |
(659)
|
(630)
|
(621)
|
(612)
|
(606)
|
(595)
|
(564)
|
(506)
|
(522)
|
(489)
|
(473)
|
(500)
|
(549)
|
(634)
|
(739)
|
(859)
|
(922)
|
(951)
|
(948)
|
(1 030)
|
(1 064)
|
(1 150)
|
(1 051)
|
(1 154)
|
(1 149)
|
(1 130)
|
|
Research & Development |
0
|
(26)
|
(104)
|
0
|
0
|
(56)
|
(106)
|
(80)
|
(102)
|
(86)
|
(70)
|
(63)
|
(58)
|
(61)
|
(63)
|
(74)
|
(88)
|
(98)
|
(111)
|
(126)
|
(134)
|
(148)
|
(157)
|
(176)
|
(172)
|
(162)
|
|
Depreciation & Amortization |
0
|
0
|
(22)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(29)
|
0
|
0
|
0
|
(43)
|
0
|
0
|
0
|
(88)
|
0
|
0
|
0
|
(145)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(58)
|
(57)
|
7
|
(113)
|
(112)
|
(58)
|
7
|
(76)
|
(13)
|
(7)
|
10
|
27
|
18
|
30
|
33
|
26
|
(145)
|
(156)
|
27
|
(412)
|
(233)
|
(229)
|
65
|
(258)
|
(325)
|
(278)
|
|
Operating Income |
168
N/A
|
191
+14%
|
184
-4%
|
176
-4%
|
121
-31%
|
112
-7%
|
98
-12%
|
105
+8%
|
132
+25%
|
153
+16%
|
175
+14%
|
414
+136%
|
671
+62%
|
926
+38%
|
1 174
+27%
|
1 269
+8%
|
675
-47%
|
(8)
N/A
|
(1 291)
-15 909%
|
(2 049)
-59%
|
(2 063)
-1%
|
(1 450)
+30%
|
(631)
+56%
|
(500)
+21%
|
(808)
-62%
|
(1 498)
-85%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||
Interest Income Expense |
(33)
|
(35)
|
(35)
|
(45)
|
(50)
|
(59)
|
(66)
|
(74)
|
(82)
|
(87)
|
(96)
|
(116)
|
(122)
|
(154)
|
(200)
|
(244)
|
(320)
|
(374)
|
(487)
|
(560)
|
(597)
|
(612)
|
(639)
|
(589)
|
(565)
|
(557)
|
|
Non-Reccuring Items |
(2)
|
(2)
|
0
|
(0)
|
0
|
0
|
(10)
|
0
|
(1)
|
(1)
|
(3)
|
0
|
(1)
|
(1)
|
(8)
|
(4)
|
(4)
|
(4)
|
(29)
|
(3)
|
(2)
|
(3)
|
(41)
|
4
|
6
|
1
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(23)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
|
Total Other Income |
5
|
3
|
0
|
(2)
|
(3)
|
(2)
|
1
|
(0)
|
4
|
4
|
2
|
(4)
|
17
|
17
|
17
|
8
|
(11)
|
3
|
9
|
(12)
|
(8)
|
(10)
|
28
|
39
|
40
|
36
|
|
Pre-Tax Income |
138
N/A
|
157
+14%
|
149
-5%
|
129
-13%
|
68
-47%
|
51
-25%
|
20
-61%
|
31
+56%
|
52
+67%
|
69
+32%
|
78
+13%
|
294
+277%
|
565
+92%
|
788
+39%
|
971
+23%
|
1 029
+6%
|
340
-67%
|
(383)
N/A
|
(1 822)
-376%
|
(2 623)
-44%
|
(2 670)
-2%
|
(2 075)
+22%
|
(1 295)
+38%
|
(1 045)
+19%
|
(1 327)
-27%
|
(2 019)
-52%
|
|
Net Income | |||||||||||||||||||||||||||
Tax Provision |
(18)
|
(24)
|
(27)
|
(25)
|
(20)
|
(18)
|
(10)
|
(5)
|
(2)
|
5
|
23
|
31
|
50
|
48
|
23
|
19
|
1
|
(3)
|
(29)
|
(19)
|
13
|
34
|
68
|
54
|
25
|
12
|
|
Income from Continuing Operations |
120
|
134
|
122
|
105
|
49
|
34
|
10
|
26
|
50
|
73
|
100
|
325
|
615
|
836
|
994
|
1 048
|
341
|
(385)
|
(1 851)
|
(2 642)
|
(2 657)
|
(2 041)
|
(1 227)
|
(991)
|
(1 302)
|
(2 007)
|
|
Income to Minority Interest |
(16)
|
(15)
|
(14)
|
(6)
|
12
|
16
|
20
|
8
|
(15)
|
(34)
|
(71)
|
(162)
|
(269)
|
(345)
|
(421)
|
(464)
|
(268)
|
(47)
|
331
|
609
|
623
|
451
|
188
|
124
|
131
|
251
|
|
Net Income (Common) |
104
N/A
|
119
+14%
|
108
-9%
|
99
-9%
|
61
-38%
|
49
-19%
|
30
-39%
|
33
+11%
|
35
+4%
|
39
+12%
|
29
-25%
|
163
+462%
|
346
+112%
|
491
+42%
|
573
+17%
|
584
+2%
|
72
-88%
|
(432)
N/A
|
(1 520)
-252%
|
(2 034)
-34%
|
(2 034)
0%
|
(1 590)
+22%
|
(1 039)
+35%
|
(867)
+17%
|
(1 172)
-35%
|
(1 756)
-50%
|
|
EPS (Diluted) |
0.23
N/A
|
0.26
+13%
|
0.22
-15%
|
0.17
-23%
|
0.12
-29%
|
0.09
-25%
|
0.05
-44%
|
0.06
+20%
|
0.07
+17%
|
0.07
N/A
|
0.05
-29%
|
0.29
+480%
|
0.61
+110%
|
0.72
+18%
|
0.91
+26%
|
0.79
-13%
|
0.1
-87%
|
-0.64
N/A
|
-2.34
-266%
|
-3.11
-33%
|
-2.62
+16%
|
-1.9
+27%
|
-1.34
+29%
|
-1.01
+25%
|
-1.32
-31%
|
-2.04
-55%
|